0
Arbutus Biopharma Corporation Banner Image

Arbutus Biopharma Corporation

  • Ticker ABUS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arbutus Biopharma Corporation Logo Image
  • 51-200 Employees
  • Based in Warminster, Pennsylvania
Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering,developing and commercializing a cure for people with chronic hepatitis B virus ("HBV") infection. They are advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discoveryMore and development effort for treating coronaviruses (including COVID-19).
REPORT RATINGS
4.8 / 5.0 (206)

Arbutus Biopharma Corporation reports have an aggregate usefulness score of 4.8 based on 206 reviews.

Arbutus Biopharma Corporation

Most Recent Annual Report

Arbutus Biopharma Corporation
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Arbutus Biopharma Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!